Skip to main content
. 2021 Jun 28:izab150. doi: 10.1093/ibd/izab150

Table 1.

Baseline Characteristics of Patients and Control Patients

Patients With IBD (n = 1032) Control Patients (n = 410) P
Sex, female 690 (66.9%) 328 (80%) <0.001
Age, y 43 (33/54) 35 (26/42) <0.001
Body weight, kg 72 (62/86) 72.7 (63/87) 0.845
Smoker 177 (17.1%) 89 (21.7%) 0.001
Former smoker 300 (29.1%) 74 (18.4%) <0.001
No comorbidity 597 (57.8%) 141 (34.4%) <0.001
Stroke 19 (1.8%) 0 0.073
Pulmonary disease 126 (12.2%) 39 (9.5%) 0.008
Diabetes mellitus 52 (5.0%) 13 (3.2%) 0.618
Arterial hypertension 202 (19.6%) 52 (12.7%) 0.092
Coronary heart disease 19 (1.8%) 4 (1.0%) 1.000
Peripheral arterial disease 12 (1.2%) 1 (0.2%) 0.522
Chronic kidney disease 43 (4.2%) 6 (1.5%) 0.451
Chronic liver disease 48 (4.7%) 0 0.003
Rheumatic disease 111 (17.8%) 7 (1.7%) 0.001
Psoriasis 86 (8.3%) 14 (3.4%) 0.486
Cancer 71 (6.9%) 14 (3.4%) 1.000
Solid organ transplant 2 (0.2%) 4 (1.0%) 0.007

All data are presented as mean and first/third quartile or as number and percentage